We speculate that lower levels of CEBPA expression in the lungs of patients with IPF are a central feature of chronic lung injury characterized by AT2 cell loss, persistent inflammation, and disrupted tissue homeostasis. Here, CEBPA is linked to idiopathic pulmonary fibrosis.